Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0344 | 1 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0151 | 0.4115 | 0.4115 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0151 | 0.4115 | 0.3596 |
Schistosoma mansoni | hypothetical protein | 0.0344 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0811 | 0.0811 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0344 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0811 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0344 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0811 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0151 | 0.4115 | 0.3596 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0285 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0188 | 0.523 | 0.4809 |
Echinococcus multilocularis | Transglutaminase | 0.0344 | 1 | 1 |
Echinococcus granulosus | Transglutaminase | 0.0344 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0151 | 0.4115 | 0.3596 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0285 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0188 | 0.523 | 0.4809 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0285 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0151 | 0.4115 | 1 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0344 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0811 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0026 | 0.0285 | 0.5 |
Mycobacterium ulcerans | transglutaminase family protein | 0.0344 | 1 | 0.5 |
Echinococcus multilocularis | geminin | 0.0188 | 0.523 | 0.4809 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0151 | 0.4115 | 0.3596 |
Echinococcus granulosus | geminin | 0.0188 | 0.523 | 0.4809 |
Leishmania major | hypothetical protein, conserved | 0.0026 | 0.0285 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0026 | 0.0285 | 0.5 |
Mycobacterium ulcerans | putative transglutaminase-like protein | 0.0344 | 1 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0285 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0151 | 0.4115 | 0.3596 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0811 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0151 | 0.4115 | 0.3596 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0026 | 0.0285 | 0.5 |
Onchocerca volvulus | 0.0344 | 1 | 0.5 | |
Mycobacterium ulcerans | hypothetical protein | 0.0344 | 1 | 0.5 |
Trichomonas vaginalis | peptide N-glycanase, putative | 0.0344 | 1 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0344 | 1 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0344 | 1 | 0.5 |
Brugia malayi | hypothetical protein | 0.0026 | 0.0285 | 0.0285 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0151 | 0.4115 | 0.3596 |
Mycobacterium tuberculosis | Long conserved protein | 0.0344 | 1 | 0.5 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0344 | 1 | 0.5 |
Giardia lamblia | Transglutaminase/protease, putative | 0.0344 | 1 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0344 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 14.581 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 23.0999 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.